Search filters

List of works by Mercè Boada

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

scientific article published on 8 December 2017

ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy

scientific article published on 09 April 2010

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

scientific article published on 20 August 2020

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

scientific article

Analysis of shared heritability in common disorders of the brain

scientific article published on 21 June 2018

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

scientific article published on 17 October 2019

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

scientific article published on 17 September 2020

CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.

scientific article published in January 2010

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain

scientific article published on 24 August 2020

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

scientific article published on 7 June 2021

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

scientific article published on 18 January 2020

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

scholarly article published in Alzheimers Research & Therapy

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7].

scientific article published on 17 September 2014

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

scientific article published on 31 July 2010

Exploratory analysis of seven Alzheimer's disease genes: disease progression

scientific article

Frontotemporal dementia and its subtypes: a genome-wide association study

scientific article

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

scientific article published on 07 May 2019

GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population.

scientific article published in January 2009

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

scientific article

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 28 February 2019

Genetic study of neurexin and neuroligin genes in Alzheimer's disease.

scientific article published in January 2013

Investigation of c9orf72 in 4 neurodegenerative disorders

scientific article published on December 2012

Long runs of homozygosity are associated with Alzheimer's disease

scientific article published on 24 February 2021

MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.

scientific article published on 15 September 2011

Molecular evaluation of human Ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients

article

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

scientific article published in May 2023

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

scientific article

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

scientific article

Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia

scientific article published on 17 February 2018

Reliable Measurements of theβ-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

scientific article published on August 16, 2012

Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment

scientific article published on January 1, 2013

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

scientific article published on 23 December 2016

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

scientific article

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.

scientific article published on 31 May 2011

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

scientific article published on January 9, 2013